{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:49:55Z","timestamp":1761630595765},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.diagmicrobio.2011.09.023","type":"journal-article","created":{"date-parts":[[2011,11,11]],"date-time":"2011-11-11T14:11:04Z","timestamp":1321020664000},"page":"113-117","source":"Crossref","is-referenced-by-count":21,"title":["Telavancin activity tested against a contemporary collection of Gram-positive pathogens from USA Hospitals (2007\u20132009)"],"prefix":"10.1016","volume":"72","author":[{"given":"Rodrigo E.","family":"Mendes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helio S.","family":"Sader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald N.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2011.09.023_bb0005","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard","author":"Clinical and Laboratory Standards Institute","year":"2009"},{"key":"10.1016\/j.diagmicrobio.2011.09.023_bb0010","series-title":"Performance standards for antimicrobial susceptibility testing: 21st Informational supplement","author":"Clinical and Laboratory Standards Institute","year":"2011"},{"key":"10.1016\/j.diagmicrobio.2011.09.023_bb0015","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1128\/AAC.00062-10","article-title":"Comparative efficacies of human\u00a0simulated exposures of telavancin and vancomycin against methicillin-resistant Staphylococcus aureus with a range of vancomycin MICs in a murine pneumonia model","volume":"54","author":"Crandon","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.09.023_bb0020","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1128\/AAC.01641-07","article-title":"Comparative surveillance study of telavancin activity against recently collected Gram-positive clinical isolates from across the United States","volume":"52","author":"Draghi","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.09.023_bb0025","author":"EUCAST"},{"key":"10.1016\/j.diagmicrobio.2011.09.023_bb0030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.diagmicrobio.2010.09.017","article-title":"In vitro activity of telavancin and comparator antimicrobial agents against a panel of genetically defined staphylococci","volume":"69","author":"Farrell","year":"2011","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.09.023_bb0035","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/jac\/dkq028","article-title":"Activity of telavancin against heterogeneous vancomycin-intermediate Staphylcoccus aureus (hVISA) in vitro and an in vivo mouse model of bacteraemia","volume":"65","author":"Hegde","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.09.023_bb0040","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.49.3.1127-1134.2005","article-title":"Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus","volume":"49","author":"Higgins","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.09.023_bb0045","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1128\/AAC.01398-07","article-title":"In vitro activity of telavancin against resistant Gram-positive bacteria","volume":"52","author":"Krause","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.09.023_bb0050","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ijantimicag.2011.02.007","article-title":"Comparative in vitro activity of telavancin, vancomycin and linezolid against heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA)","volume":"37","author":"Leonard","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.diagmicrobio.2011.09.023_bb0055","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1128\/AAC.01544-08","article-title":"Activity of telavancin against Staphylococcus aureus strains with various vancomycin susceptibilities in an in vitro pharmacokinetic\/pharmacodynamic model with simulated endocardial vegetations","volume":"53","author":"Leonard","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.09.023_bb0060","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1128\/AAC.01143-09","article-title":"Antistaphylococcal activities of telavancin tested alone and in combination by time\u2013kill assay","volume":"54","author":"Lin","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.09.023_bb0065","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1128\/AAC.01710-08","article-title":"Telavancin disrupts the functional integrity of the bacterial membrane through targeted interaction with the cell wall precursor lipid II","volume":"53","author":"Lunde","year":"2009","journal-title":"Antimicrob. Agents. Chemother:. Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.09.023_bb0080","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.diagmicrobio.2010.03.009","article-title":"Worldwide summary of telavancin spectrum and potency against Gram-positive pathogens: 2007 to 2008 surveillance results","volume":"67","author":"Putnam","year":"2010","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.09.023_bb0085","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/jac\/dkl222","article-title":"Efficacy of telavancin in a murine model of\u00a0bacteraemia induced by methicillin-resistant Staphylococcus aureus","volume":"58","author":"Reyes","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.09.023_bb0090","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/cid\/ciq031","article-title":"Telavancin versus vancomycin for hospital-acquired pneumonia due to Gram-positive pathogens","volume":"52","author":"Rubinstein","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.09.023_bb0095","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1086\/587896","article-title":"Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by Gram-positive organisms","volume":"46","author":"Stryjewski","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.09.023_bb0100","series-title":"Package insert","author":"VIBATIV","year":"2009"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889311004020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889311004020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T12:25:21Z","timestamp":1543407921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889311004020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0732889311004020"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2011.09.023","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}